Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Bayesian interim analysis of phase II cancer clinical trials
Daniel F. Heitjan
Clinical Sciences
Clinical Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
76
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bayesian interim analysis of phase II cancer clinical trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Mathematics
Alternatives
17%
Bayesian Analysis
75%
Calculate
10%
Cancer
73%
Clinical Trials
67%
Critical value
13%
Design
44%
Error Probability
16%
Evidence
35%
Exceed
13%
Imply
8%
Interim Analysis
100%
Null
12%
Optimality
11%
Optimise
14%
Persuasion
71%
Posterior Probability
16%
Standards
23%
Strictly
10%
Termination
14%
Therapy
16%
Medicine & Life Sciences
Bayes Theorem
87%
Investigational Therapies
17%
Neoplasms
23%
Persuasive Communication
62%
Phase II Clinical Trials
86%
Therapeutics
2%